Author

Atsushi Goto

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Real-world effectiveness of SGLT2 inhibitors in adults aged 75 years or older: a target trial emulation.

Among adults aged ≥75 years with type 2 diabetes, SGLT2i initiation was associated with lower all-cause mortality and renal risk compared with DPP-4i initiation, and the higher observed stroke risk requires cautious interpretation.

H. Noma, Atsushi Goto, T. Sugimoto et al. · Age and Ageing · 1 citation